Cumulative exposure to IGF-1 excess was associated with a higher cancer risk among patients with acromegaly ... Common cancers included breast cancer among women (11%), prostate cancer among men (5.8% ...

With infrastructure spending on the rise, now could be an opportune time to invest in top infrastructure ETFs like Global X U ...

Acelyrin's Lonigutamab offers a competitive edge with subcutaneous administration, higher potency, and lower adverse events.

Biomed Industries Unveils novel Quadruple Receptor Agonist for weight loss with Minimal Adverse Effects at the International Obesity conference in Las Vegas Dr. Lloyd L. Tran Biomed Industries, Inc.

Glucose or glucose syrup: also known as dextrose, often found in processed foods. Honey, agave syrup, maple syrup: often ...

With the internet and many different social media sites, it is getting difficult to keep track of the new trends, a latest in ...

Most of us consume at least twice as much sugar as the recommendations allow. Basically, most of the sugar we consume isn’t ...

The 2-in-1 form factor has certainly come into its own over the last several years. There's really no reason to limit yourself to a clamshell, as there's a 2-in-1 that will meet the needs of all ...

Findings showed 72.2% of patients treated with Oclaiz had a biochemical response compared with 37.5% of those who received placebo (primary endpoint; mean insulin-like growth factor [IGF-1] ≤upper ...

Learn more about whether ACADIA Pharmaceuticals Inc or Centessa Pharmaceuticals PLC - ADR is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics ...

At long last, Arcane season 2 has an official release date. Well, three launch dates, to be exact, but that was to be expected, what with the multi-award-winning Netflix show's first season doing ...

We circle back to three small biotech stocks that recently were positively highlighted and moved up on good news. Explore ...